Posts by Arron Zhang

Enhancing diversity, equity and inclusion (DEI) in clinical trial populations is a moral imperative. It has long been acknowledged that DEI is crucial for broadening the scope, creativity and innovativeness of medical research and bolsters success in solving complex problems whilst reducing inequities in health and disease.

Effective continuing medical education (CME) programmes raise standards and enable HCPs to improve knowledge and skills through lifelong learning.